This randomized, controlled study compared the ability to mobilize and collect an optimal
target yield of 5× 10 6 CD34+ cells/kg using stem cell factor (SCF; 20 μg/kg/day) plus …

The number of CD34+ cells has been described as the best parameter for predicting the
quality of engraftment in peripheral blood progenitor cell (PBPC) transplantation in the early …

We analyzed the prognostic factors for a successful mobilization and peripheral blood stem
cell collection in a series of 57 consecutive patients with multiple myeloma (MM); a new …

Background Peripheral blood stem cell (PBSC) mobilization is routinely undertaken prior to
autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM). A …

In all, 78 peripheral hematopoietic progenitor cell collections from 52 patients were
evaluated using our previously published validated post-thaw assays at the time of …

Background: We analyzed the hematopoietic reconstitution and outcome of 508 patients
with multiple myeloma (MM) with respect to the number of CD34+ cells reinfused at our …

PURPOSE: Conventional allogeneic stem-cell transplantation (SCT) after a prior failed
autograft is associated with a transplant-related mortality rate of 50% to 80%. The aim of the …

Regulation of hematopoietic stem cell release, migration, and homing from the bone marrow
(BM) and of the mobilization pathway involves a complex interaction among adhesion …

Several stem cell mobilization strategies have been employed in the past 2 decades,
including chemotherapy, hematopoietic growth factors, and chemotherapy plus growth …

Better methods to characterize normal human hematopoietic cells with short-term
repopulating activity cells (STRCs) are needed to facilitate improving recovery rates in …